The Problem: Manual CoA Assembly in a High-Stakes, Time-Critical Process
Gene therapy viral vector manufacturing runs at a cost scale of $5M–$50M per batch program, and the quality release process is governed by a Qualified Person whose signature authorizes release. The QP's review depends on a complete lot-disposition package: certificate-of-analysis data from contract testing labs, adventitious agent and sterility results trended against historical performance, and a lot-disposition summary memo that documents the disposition decision logic. Assembling that package manually — pulling from MasterControl and OSIsoft PI historian, chasing results from multiple CTLs, running the CQA trend analysis — takes weeks and involves significant QA contractor time.
How an AI Agent Approaches It
An AI Labor Company agent mines vector-release testing and lot-disposition workflows from manufacturing team data in MasterControl and the OSIsoft PI historian. It auto-compiles certificate-of-analysis data from contract testing labs, runs adventitious agent and sterility result trending against the historical CQA baseline, and generates the lot-disposition summary memo for QP review. The Qualified Person reviews and approves all critical quality attribute deviations before release — the agent handles the compilation, trending, and memo generation, not the QP certification. The process replaces weeks of manual QA contractor work with a structured, auditable documentation workflow.
What This Is Worth
Reducing the lot-disposition cycle by three weeks on a viral vector batch program has direct clinical and financial implications: faster availability for clinical use, reduced holding costs, and compressed time-to-clinic for patients. The cost savings are also concrete — external QA contractor spend on lot-disposition documentation typically runs $1M per batch program, and teams using this approach see 30–50% reductions in overall quality-release administrative burden. The agent is operational in roughly 20 weeks, accounting for the complexity of MasterControl and PI historian integration in a GMP manufacturing environment.
How does the agent handle results that fall outside the established CQA acceptance criteria?
Out-of-specification or out-of-trend results are flagged immediately and escalated to the Qualified Person with the relevant data context. The agent does not make disposition recommendations on flagged results — all CQA deviation decisions require QP review and approval.
Is the agent compliant with 21 CFR Part 11 electronic records requirements?
21 CFR Part 11 compliance depends on how the agent's outputs are stored and controlled within your validated systems. MasterControl integration can be configured to route agent-generated documents through your existing Part 11-compliant review and approval workflows — this is addressed during implementation scoping.